Philips HeartStart FR3 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Philips Electronics Australia Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2014-RN-00267-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2014-03-04
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    In a limited number of fr3 aeds, the printed circuit board (pcb), which contains the circuitry that supplies energy to the device, could become separated from the electrical contact points that hold the board in place. in the event that pcb becomes separated from the electrical contact points, the aed may not be ready to deliver a shock in the event of an emergency.
  • 조치
    Philips is advising users to continue to use the AED if there are no alternatives available. Customer who have the affected device will be supplied with a replacement AED from Philips. This action has been closed-out on 12/02/2016.

Device

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DHTGA